Bank of New York Mellon Corp
BankPosition in ZVRA — Zevra Therapeutics, Inc.
CIK 1390777
NEW YORK, NY
Position in ZVRA
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$1,607,017
+$46,591 QoQ
Shares Held
172,427
-1.0% QoQ
Ownership
0.292%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
20 quarters on record
Voting authority
Sole 98.69567991091883.ToString("F0")%
Shared 0.ToString("F0")%
None 1.3043200890811764.ToString("F0")%
Common Shares in ZVRA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Bank of New York Mellon Corp holds $4,203,063,863 across 270 Biotechnology names. ZVRA ranks #145 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,586,427 | $708,403,098 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
765,411 | $591,387,145 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,679,371 | $317,485,079 | |
| 4 | INSM |
INSMED Inc
|
1,262,749 | $206,484,708 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
491,200 | $162,523,337 | |
| 6 | INCY |
Incyte Corp
|
989,709 | $93,151,403 | |
| 7 | TECH |
BIO-TECHNE Corp
|
1,759,119 | $91,931,549 | |
| 8 | MRNA |
Moderna, Inc.
|
1,691,205 | $85,913,207 |
All Filings in ZVRA
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,607,017 | 172,427 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $1,560,426 | 174,155 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $1,196,651 | 125,831 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $1,048,167 | 118,975 | Shares | Defined | 2025-08-05 | |
| 2025-03-31 | $902,041 | 120,433 | Shares | Defined | 2025-04-29 | |
| 2024-12-31 | $904,781 | 108,487 | Shares | Defined | 2025-02-04 | |
| 2024-09-30 | $1,012,210 | 145,852 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $1,080,443 | 220,499 | Shares | Defined | 2024-07-25 | |
| 2024-03-31 | $1,155,753 | 199,268 | Shares | Defined | 2024-04-25 | |
| 2023-12-31 | $1,328,161 | 202,773 | Shares | Defined | 2024-01-29 | |
| 2023-09-30 | $977,364 | 202,773 | Shares | Defined | 2023-10-24 | |
| 2023-06-30 | $1,034,702 | 202,883 | Shares | Defined | 2023-08-03 | |
| 2023-03-31 | $630,442 | 114,626 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $526,131 | 114,626 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $737,355 | 118,166 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $527,019 | 118,166 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $822,992 | 163,617 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $760,765 | 87,344 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $797,284 | 85,454 | Shares | Defined | 2021-11-18 | |
| 2021-06-30 | $931,307 | 72,645 | Shares | Defined | 2021-08-11 | |
| No filing history on record for this holder in this stock. | ||||||